Добірка наукової літератури з теми "Vaccinia virus"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Vaccinia virus".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Vaccinia virus"
Tartaglia, James, and Enzo Paoletti. "Recombinant vaccinia virus vaccines." Trends in Biotechnology 6, no. 2 (February 1988): 43–46. http://dx.doi.org/10.1016/0167-7799(88)90035-2.
Повний текст джерелаDoria-Rose, N. A., C. Ohlen, P. Polacino, C. C. Pierce, M. T. Hensel, L. Kuller, T. Mulvania, et al. "Multigene DNA Priming-Boosting Vaccines Protect Macaques from Acute CD4+-T-Cell Depletion after Simian-Human Immunodeficiency Virus SHIV89.6P Mucosal Challenge." Journal of Virology 77, no. 21 (November 1, 2003): 11563–77. http://dx.doi.org/10.1128/jvi.77.21.11563-11577.2003.
Повний текст джерелаKUTINOVA, L. "Search for optimal parent for recombinant vaccinia virus vaccines. Study of three vaccinia virus vaccinal strains and several virus lines derived from them." Vaccine 13, no. 5 (1995): 487–93. http://dx.doi.org/10.1016/0264-410x(94)00019-j.
Повний текст джерелаPrecopio, Melissa L., Michael R. Betts, Janie Parrino, David A. Price, Emma Gostick, David R. Ambrozak, Tedi E. Asher, et al. "Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses." Journal of Experimental Medicine 204, no. 6 (May 29, 2007): 1405–16. http://dx.doi.org/10.1084/jem.20062363.
Повний текст джерелаTruong, Cao-Sang, and So Young Yoo. "Oncolytic Vaccinia Virus in Lung Cancer Vaccines." Vaccines 10, no. 2 (February 4, 2022): 240. http://dx.doi.org/10.3390/vaccines10020240.
Повний текст джерелаJacobs, Bertram L., Jeffrey O. Langland, Karen V. Kibler, Karen L. Denzler, Stacy D. White, Susan A. Holechek, Shukmei Wong, Trung Huynh, and Carole R. Baskin. "Vaccinia virus vaccines: Past, present and future." Antiviral Research 84, no. 1 (October 2009): 1–13. http://dx.doi.org/10.1016/j.antiviral.2009.06.006.
Повний текст джерелаSmith, Geoffrey L., Brendan J. Murphy, and Mansun Law. "Vaccinia Virus Motility." Annual Review of Microbiology 57, no. 1 (October 2003): 323–42. http://dx.doi.org/10.1146/annurev.micro.57.030502.091037.
Повний текст джерелаPerkus, M. E. "RECOMBINANT VACCINIA VIRUS." Pediatric Infectious Disease Journal 5, no. 2 (March 1986): 284. http://dx.doi.org/10.1097/00006454-198603000-00045.
Повний текст джерелаBroyles, Steven S. "Vaccinia virus transcription." Journal of General Virology 84, no. 9 (September 1, 2003): 2293–303. http://dx.doi.org/10.1099/vir.0.18942-0.
Повний текст джерелаStittelaar, Koert J., Geert van Amerongen, Ivanela Kondova, Thijs Kuiken, Rob F. van Lavieren, Frank H. M. Pistoor, Hubert G. M. Niesters, et al. "Modified Vaccinia Virus Ankara Protects Macaques against Respiratory Challenge with Monkeypox Virus." Journal of Virology 79, no. 12 (June 15, 2005): 7845–51. http://dx.doi.org/10.1128/jvi.79.12.7845-7851.2005.
Повний текст джерелаДисертації з теми "Vaccinia virus"
Chan, Kenneth See Kit. "Nef from pathogenic simian immunodeficiency virus attenuates vaccinia virus /." For electronic version search Digital dissertations database. Restricted to UC campuses. Access is free to UC campus dissertations, 2004. http://uclibs.org/PID/11984.
Повний текст джерелаWallengren, Kristina. "Envelopment of retrovirus and vaccinia virus /." Stockholm, 2001. http://diss.kib.ki.se/2001/91-628-4851-8/.
Повний текст джерелаKettle, Susan. "Characterisation of vaccinia virus gene B13R." Thesis, University of Oxford, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.294390.
Повний текст джерелаMoore, Jeffrey B. "Vaccinia virus 3[beta]-hydroxysteroid dehydrogenase." Thesis, University of Oxford, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.359450.
Повний текст джерелаKeller, Brian Andrew. "Functional Genomic Studies of Vaccinia Virus Provide Fundamental Insights into Virus-Host Interactions." Thesis, Université d'Ottawa / University of Ottawa, 2017. http://hdl.handle.net/10393/36614.
Повний текст джерелаBleckwenn, Nicole Aleece. "Protein production development with recombinant vaccinia virus." College Park, Md. : University of Maryland, 2004. http://hdl.handle.net/1903/1416.
Повний текст джерелаThesis research directed by: Chemical Engineering. Title from t.p. of PDF. Includes bibliographical references. Published by UMI Dissertation Services, Ann Arbor, Mich. Also available in paper.
Gardner, Jeremy Damien. "Characterisation of the vaccinia virus gene A39R." Thesis, University of Oxford, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.365448.
Повний текст джерелаMajor, James R. "Interactions of dendritic cells with vaccinia virus." Thesis, University of Oxford, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.401096.
Повний текст джерелаOdell, Mark. "An analysis of vaccinia virus DNA ligase." Thesis, University of Oxford, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.670258.
Повний текст джерелаNapoli, Andrea. "Glycerophospholipid fluorescence imaging during vaccinia virus replication." Thesis, Sorbonne Paris Cité, 2019. https://theses.md.univ-paris-diderot.fr/NAPOLI_Andrea_1_va_20190415.pdf.
Повний текст джерелаVaccinia Virus (VACV) is the model organism for the study of the Poxviridae. Its cytoplasmic life cycle has been studied extensively by light- and electron microscopy. Thanks to a robust genetic system the role of some of its 250 proteins is beginning to be understood. Nevertheless, the acquisition of its membranes is still a matter of debate, in particular the role of cellular lipids. Lipid mass spectrometry of purified VACV previously showed an enrichment of phosphatidic acid (PA) and phosphatidylinositol derivatives (PIPs) in the viral membrane. Although some viral proteins have been shown to bind PIPs in vitro the role of these lipids in the viral life cycle, in particular viral membrane biogenesis, remains elusive.The aim of this work is to determine whether PA and PIPs are relocated in infected cells to the site of viral membrane biogenesis. For both PA and PIPs, I used recombinant proteins containing PA or PIP binding domains fused to eGFP, expressed them by transient transfection to follow their localization during viral replication. In addition, I used antibodies for the recognition of PI4K and PI4P. In order to understand the biochemical role of PIPs, I used pan-PI3K and PI4K inhibitors to study their effect on viral assembly. Using these tools, I could show that the lipids under investigation did not display an altered localization, with the exception of PI3P which showed a different pattern in infected cells. None of the PIPs analyzed co-localized with the sites of primary VACV membrane biogenesis. Consistent with the fact that the mature virus acquires additional membranes derived from the Golgi complex, I could show a co-localization of wrapped virus with PI4P, known to localize to this cellular organelle. However, drugs inhibiting PI3P and PI4P biosynthesis did not show any effect on VACV membrane biogenesis, at least at the light microscopy level. In conclusion, this work sharper defines the role of lipids during VACV replication. In particular, it opens the way to further studies on the putative role of PI4P during wrapping and the fate of PI3P and PI3P binding proteins during late replication
Книги з теми "Vaccinia virus"
Mercer, Jason, ed. Vaccinia Virus. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9593-6.
Повний текст джерелаIsaacs, Stuart N., ed. Vaccinia Virus and Poxvirology. Totowa, NJ: Humana Press, 2004. http://dx.doi.org/10.1385/1592597890.
Повний текст джерелаIsaacs, Stuart N., ed. Vaccinia Virus and Poxvirology. Totowa, NJ: Humana Press, 2012. http://dx.doi.org/10.1007/978-1-61779-876-4.
Повний текст джерелаBennett, Alice Marie. Co-expression of vaccine antigens in vaccinia virus. Manchester: University of Manchester, 1995.
Знайти повний текст джерелаNeal, Isaacs Stuart, ed. Vaccinia virus and poxvirology: Methods and protocols. Totowa, N.J: Humana Press, 2004.
Знайти повний текст джерелаCarroll, Miles William. Expression analysis and immunogenicity of human immunodeficiency virus type 1 envelopeglycoprotein in vaccinia virus. Manchester: University of Manchester, 1993.
Знайти повний текст джерелаXu, Fan. Construction of vaccinia virus recombinants carrying fragments of the rotavirus gene encoding VP7. [s.l.]: typescript, 1994.
Знайти повний текст джерелаSchneider, Henriette. Rescue of measles virus using the vaccinia vector MVA-T7 & analysis of recombinant measles viruses mutated in the RNA editing site. [s.l.]: [s.n.], 1996.
Знайти повний текст джерелаFerran, Maureen C., and Gary R. Skuse, eds. Recombinant Virus Vaccines. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-6869-5.
Повний текст джерела1919-, Fukai Kōnosuke, and Japan Intractable Diseases Research Foundation., eds. Virus vaccines in Asian countries. [Tokyo]: University of Tokyo Press, 1986.
Знайти повний текст джерелаЧастини книг з теми "Vaccinia virus"
Smith, G. L. "Recombinant vaccinia virus vaccines." In Recent Developments in Prophylactic Immunization, 313–33. Dordrecht: Springer Netherlands, 1989. http://dx.doi.org/10.1007/978-94-009-1067-6_15.
Повний текст джерелаBartlett, D. L. "Vaccinia Virus." In Monographs in Virology, 130–59. Basel: KARGER, 2001. http://dx.doi.org/10.1159/000061723.
Повний текст джерелаShida, Hisatoshi. "Vaccinia Virus Hemagglutinin." In Subcellular Biochemistry, 405–40. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4899-1675-4_12.
Повний текст джерелаMoss, Bernard. "Vaccinia virus vectors." In Biotechnology for Solving Agricultural Problems, 317–23. Dordrecht: Springer Netherlands, 1986. http://dx.doi.org/10.1007/978-94-009-4396-4_24.
Повний текст джерелаMoss, B. "Vaccinia Virus Vectors: Applications to Vaccines." In Progress in Immunology, 1131–36. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-83755-5_151.
Повний текст джерелаSmith, Geoffrey L., and Alain Vanderplasschen. "Extracellular Enveloped Vaccinia Virus." In Advances in Experimental Medicine and Biology, 395–414. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5331-1_51.
Повний текст джерелаChalikonda, Sricharan, and David L. Bartlett. "Vaccinia and Pox-Virus." In Gene Therapy for Cancer, 73–85. Totowa, NJ: Humana Press, 2007. http://dx.doi.org/10.1007/978-1-59745-222-9_4.
Повний текст джерелаMoss, Bernard. "Vaccinia Virus Expression Vectors." In Progress in Vaccinology, 415–21. New York, NY: Springer New York, 1989. http://dx.doi.org/10.1007/978-1-4612-3508-8_39.
Повний текст джерелаRooney, James F., Charles R. Wohlenberg, and Abner Louis Notkins. "Vaccinia Virus Recombinants as Potential Herpes Simplex Virus Vaccines." In Genetically Engineered Vaccines, 183–89. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3410-5_20.
Повний текст джерелаIsaacs, Stuart N. "Working Safely with Vaccinia Virus." In Vaccinia Virus and Poxvirology, 1–13. Totowa, NJ: Humana Press, 2004. http://dx.doi.org/10.1385/1-59259-789-0:001.
Повний текст джерелаТези доповідей конференцій з теми "Vaccinia virus"
Protsenko, M. A., E. I. Filippova, E. V. Makarevich, I. A. Gorbunova, T. V. Teplyakova, and N. A. Mazurkova. "ANTIVIRAL PROPERTIES OF EXTRACTS OF BASIDIOMYCETES OF THE NOVOSIBIRSK REGION." In X Международная конференция молодых ученых: биоинформатиков, биотехнологов, биофизиков, вирусологов и молекулярных биологов — 2023. Novosibirsk State University, 2023. http://dx.doi.org/10.25205/978-5-4437-1526-1-259.
Повний текст джерелаRaafat, Nermin, Chantal Mengus, Michael Heberer, Giulio C. Spagnoli, and Paul Zajac. "Abstract 1500: Modulation of recombinant vaccinia virus vector immunogenicity." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-1500.
Повний текст джерелаWang, Weiyi, Peihong Dai, Ning Yang, Stewart Shuman, Taha Merghoub, Jedd D. Wolchok, and Liang Deng. "Abstract A007: Intratumoral delivery of inactivated vaccinia virus is more efficacious than live oncolytic vaccinia virus in murine bilateral tumor implantation models." In Abstracts: Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; September 25-28, 2016; New York, NY. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/2326-6066.imm2016-a007.
Повний текст джерелаRamachandran, Mohanraj, and Magnus Essand. "Abstract B181: Adenovirus, Semliki Forest virus and vaccinia virus-induced immunogenic cell death augments oncolytic virus immunotherapy." In Abstracts: Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; September 30 - October 3, 2018; New York, NY. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/2326-6074.cricimteatiaacr18-b181.
Повний текст джерелаTrella, Emanuele. "Abstract A016: Multipotency of a CD40L-expressing recombinant vaccinia virus." In Abstracts: Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; September 25-28, 2016; New York, NY. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/2326-6066.imm2016-a016.
Повний текст джерелаKonyakhina, Yu V., A. A. Sergeev, K. A. Titova, S. A. Pyankov, S. N. Yakubitskiy, and S. N. Shchelkunov. "LOW-DOSE SMALLPOX VACCINATION IN A MOUSE MODEL." In X Международная конференция молодых ученых: биоинформатиков, биотехнологов, биофизиков, вирусологов и молекулярных биологов — 2023. Novosibirsk State University, 2023. http://dx.doi.org/10.25205/978-5-4437-1526-1-254.
Повний текст джерелаShulgina, I. S., S. N. Yakubitskiy, A. A. Sergeev, K. A. Titova, M. B. Borgoyakova, E. V. Starostina, L. I. Karpenko, and S. N. Shchelkunov. "EFFECT OF THE ATI GENE DELETION ON PATHOGENICITY AND IMMUNOGENICITY OF THE VACCINIA VIRUS." In X Международная конференция молодых ученых: биоинформатиков, биотехнологов, биофизиков, вирусологов и молекулярных биологов — 2023. Novosibirsk State University, 2023. http://dx.doi.org/10.25205/978-5-4437-1526-1-268.
Повний текст джерелаKim, Jee Hung, Woo Sun Kwon, Tae Soo Kim, Kyu Hyun Park, Joong Bae Ahn, Namhee Lee, Ji Won Choi, Hyun Cheol Chung, and Sun Young Rha. "Abstract B132: Antitumor effect of oncolytic vaccinia virus in gastric cancer." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; October 26-30, 2017; Philadelphia, PA. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1535-7163.targ-17-b132.
Повний текст джерелаPanopoulos, Evangelos, Emanuele Trella, Nermin Raafat, Chantal Mengus, Giulio Spagnoli, and Paul Zajac. "Abstract 2843: Recombinant Vaccinia virus expressing CD40L: a multipotent antitumor immunogenic reagent." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-2843.
Повний текст джерелаTIMIRYASOVA, TATYANA M., YONG A. YU, SHAHROKH SHABAHANG, ISTVAN FODOR, and ALADAR A. SZALAY. "VISUALIZATION OF VACCINIA VIRUS INFECTION USING THE RENILLA-LUCIFERASE-GFP FUSION PROTEIN." In Proceedings of the 11th International Symposium. WORLD SCIENTIFIC, 2001. http://dx.doi.org/10.1142/9789812811158_0111.
Повний текст джерелаЗвіти організацій з теми "Vaccinia virus"
Buckley, Patricia E., Kevin P. O'Connell, and Gary D. Ouellette. Review of Vaccinia Virus and Baculovirus Viability Versus Virucides. Fort Belvoir, VA: Defense Technical Information Center, March 2008. http://dx.doi.org/10.21236/ada480422.
Повний текст джерелаSchurig, Gerhardt G. Expression of Brucella Antigens in Vaccinia Virus to Prevent Brucellosis in Humans: Protection Studies in Mice. Fort Belvoir, VA: Defense Technical Information Center, August 2000. http://dx.doi.org/10.21236/ada382850.
Повний текст джерелаGates, Sean Damien. Biophysical analysis of bacterial and viral systems. A shock tube study of bio-aerosols and a correlated AFM/nanosims investigation of vaccinia virus. Office of Scientific and Technical Information (OSTI), May 2013. http://dx.doi.org/10.2172/1108845.
Повний текст джерелаButler, Nadia, and Soha Karam. Evidence Review: COVID-19 Vaccine Acceptance by Key Influencers in the MENA Region - Teachers and Healthworkers. Institute of Development Studies (IDS), November 2021. http://dx.doi.org/10.19088/sshap.2021.039.
Повний текст джерелаGeisbert, Thomas W., and Peter B. Jahrling. Towards a Vaccine Against Ebola Virus. Fort Belvoir, VA: Defense Technical Information Center, January 2003. http://dx.doi.org/10.21236/ada428607.
Повний текст джерелаKonakanchi, Lakshmi sravya. Vaccine Development for Respiratory Syncytial Virus. Ames (Iowa): Iowa State University, January 2020. http://dx.doi.org/10.31274/cc-20240624-1577.
Повний текст джерелаVakharia, Vikram, Shoshana Arad, Yonathan Zohar, Yacob Weinstein, Shamila Yusuff, and Arun Ammayappan. Development of Fish Edible Vaccines on the Yeast and Redmicroalgae Platforms. United States Department of Agriculture, February 2013. http://dx.doi.org/10.32747/2013.7699839.bard.
Повний текст джерелаHeaton, Madeline. Review of Respiratory Syncytial Virus Vaccine Developments. Ames (Iowa): Iowa State University, May 2022. http://dx.doi.org/10.31274/cc-20240624-1234.
Повний текст джерелаLublin, A., H. Ly, E. Porter, S. Mor, Y. Farnoushi, and S. M. Goyal. Novel vaccination strategies to combat chicken arthritis/tenosynovitis reoviruses in US and Israel. Israel: United States-Israel Binational Agricultural Research and Development Fund, 2020. http://dx.doi.org/10.32747/2020.8134154.bard.
Повний текст джерелаTrent, Dennis W. Development of a Genetically Engineered Venezuelan Equine Encephalitis Virus Vaccine. Fort Belvoir, VA: Defense Technical Information Center, April 1991. http://dx.doi.org/10.21236/ada237590.
Повний текст джерела